AU2002364468A1 - Solid orally-dispersible pharmaceutical formulation - Google Patents

Solid orally-dispersible pharmaceutical formulation

Info

Publication number
AU2002364468A1
AU2002364468A1 AU2002364468A AU2002364468A AU2002364468A1 AU 2002364468 A1 AU2002364468 A1 AU 2002364468A1 AU 2002364468 A AU2002364468 A AU 2002364468A AU 2002364468 A AU2002364468 A AU 2002364468A AU 2002364468 A1 AU2002364468 A1 AU 2002364468A1
Authority
AU
Australia
Prior art keywords
pharmaceutical formulation
solid orally
dispersible pharmaceutical
dispersible
orally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002364468A
Other versions
AU2002364468C1 (en
AU2002364468B2 (en
Inventor
Michel Serpelloni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roquette Freres SA
Original Assignee
Roquette Freres SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0200647A external-priority patent/FR2834889B1/en
Application filed by Roquette Freres SA filed Critical Roquette Freres SA
Publication of AU2002364468A1 publication Critical patent/AU2002364468A1/en
Application granted granted Critical
Publication of AU2002364468B2 publication Critical patent/AU2002364468B2/en
Publication of AU2002364468C1 publication Critical patent/AU2002364468C1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002364468A 2002-01-18 2002-12-19 Solid orally-dispersible pharmaceutical formulation Ceased AU2002364468C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR02/00647 2002-01-18
FR0200647A FR2834889B1 (en) 2002-01-18 2002-01-18 SOLID ORODISPERSIBLE PHARMACEUTICAL FORM
PCT/FR2002/004454 WO2003061623A1 (en) 2002-01-18 2002-12-19 Solid orally-dispersible pharmaceutical formulation

Publications (3)

Publication Number Publication Date
AU2002364468A1 true AU2002364468A1 (en) 2003-09-18
AU2002364468B2 AU2002364468B2 (en) 2008-06-26
AU2002364468C1 AU2002364468C1 (en) 2009-01-22

Family

ID=27589521

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002364468A Ceased AU2002364468C1 (en) 2002-01-18 2002-12-19 Solid orally-dispersible pharmaceutical formulation

Country Status (22)

Country Link
US (1) US7201922B2 (en)
EP (1) EP1465593B1 (en)
JP (1) JP2005515240A (en)
KR (1) KR100961367B1 (en)
CN (1) CN1248681C (en)
AT (1) ATE439828T1 (en)
AU (1) AU2002364468C1 (en)
BR (1) BR0208161A (en)
CA (1) CA2441796A1 (en)
CZ (1) CZ20032486A3 (en)
DE (1) DE60233436D1 (en)
FR (1) FR2834889B1 (en)
HU (1) HUP0303948A2 (en)
IL (2) IL158691A0 (en)
MX (1) MXPA03008420A (en)
NO (1) NO326259B1 (en)
NZ (1) NZ529694A (en)
PL (1) PL209144B1 (en)
RU (1) RU2317812C2 (en)
SK (1) SK287812B6 (en)
WO (1) WO2003061623A1 (en)
ZA (1) ZA200308664B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1128817A1 (en) * 1998-10-27 2001-09-05 Biovail Technologies Ltd Microparticles containing peg and/or peg glyceryl esters
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
FR2834894B1 (en) * 2002-01-21 2004-02-27 Servier Lab ORIBISPERSIBLE PHARMACEUTICAL COMPOSITION OF PIRIBEDIL
FR2834896B1 (en) * 2002-01-23 2004-02-27 Servier Lab ORODISPERSIBLE PHARMACEUTICAL COMPOSITION OF IVABRADINE
FR2834890B1 (en) * 2002-01-23 2004-02-27 Servier Lab ORODISPERSIBLE PHARMACEUTICAL COMPOSITION OF AGOMELATIN
FR2834893B1 (en) * 2002-01-23 2004-02-27 Servier Lab ORODISPERSIBLE PHARMACEUTICAL COMPOSITION OF PERINDOPRIL
DE10229472A1 (en) * 2002-07-01 2004-01-15 Symrise Gmbh & Co. Kg Compact milk lactate ester
FR2857263B1 (en) * 2003-07-09 2005-09-09 Sanofi Synthelabo NOVEL SOLID PHARMACEUTICAL COMPOSITION COMPRISING AMISULPRIDE
FR2858556B1 (en) * 2003-08-06 2006-03-10 Galenix Innovations DISPERSIBLE AND / OR ORODISPERSIBLE SOLID PHARMACEUTICAL COMPOSITION, NOT PELLETIZED, CONTAINING AT LEAST THE METFORMIN ACTIVE INGREDIENT, AND PROCESS FOR PREPARING THE SAME
TWI347942B (en) * 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
KR101109633B1 (en) 2007-08-03 2012-01-31 제이더블유중외제약 주식회사 Composition for manufacturing orally disintegrating dosage forms, for protecting the coating of active substance
FR2920311B1 (en) * 2007-08-31 2010-06-18 Galenix Innovations SOLID COMPOSITION, ORODISPERSIBLE AND / OR DISPERSIBLE, WITHOUT A KNOWLEDGE EXCIPIENT AND PROCESS FOR PREPARING THE SAME
EP2397161B1 (en) * 2009-02-12 2019-09-25 Fuji Chemical Industry Co., Ltd. Disintegrating particle composition and rapidly disintegrating compression-molded material comprising same
RU2497505C1 (en) * 2012-11-07 2013-11-10 Максим Эдуардович Запольский New therapeutic composition for treating pain syndrome accompanying smooth muscle spasm
RU2503447C1 (en) * 2012-11-20 2014-01-10 Максим Эдуардович Запольский Drug preparation in form of orally dispersible tablet and method for making drug preparation
EP3023109A4 (en) * 2013-07-19 2017-01-04 Sanwa Kagaku Kenkyusho Co., Ltd Orally disintegrating tablet
DE102017103346A1 (en) * 2017-02-17 2018-08-23 Lts Lohmann Therapie-Systeme Ag Structured orodispersible films
JP7138666B2 (en) * 2018-01-24 2022-09-16 大原薬品工業株式会社 METHOD FOR IMPROVING CHEMICAL STABILITY OF TABLETS CONTAINING γ-AMINOBUTYRIC ACID DERIVATIVES

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327077A (en) * 1981-05-29 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
JP3349535B2 (en) * 1993-01-12 2002-11-25 フロイント産業株式会社 Method for producing spherical granules
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
WO1998002185A1 (en) * 1996-07-12 1998-01-22 Daiichi Pharmaceutical Co., Ltd. Quickly disintegrable compression-molded materials and process for producing the same
FR2752162B1 (en) 1996-08-07 1998-11-06 Jouveinal Lab TRIMEBUTINE FILM MALEATE TABLET
FR2766089B1 (en) * 1997-07-21 2000-06-02 Prographarm Lab IMPROVED MULTIPARTICULAR TABLET WITH RAPID DELIVERY
AU3574500A (en) 1999-03-25 2000-10-16 Yuhan Corporation Rapidly disintegrable tablet for oral administration
US6316029B1 (en) * 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
ATE371439T1 (en) * 2000-07-27 2007-09-15 Roquette Freres GRANULES CONSISTING OF STARCH AND LACTOSE
US20040014680A1 (en) * 2000-10-16 2004-01-22 Hiroaki Nakagami Medicinal compositions quickly disintegrating in the oral cavity and process for producing the same
FR2823668B1 (en) * 2001-04-20 2004-02-27 Ethypharm Lab Prod Ethiques ORODISPERSIBLE EFFERVESCENT TABLETS
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
US7118765B2 (en) * 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
BR0215193A (en) * 2001-12-21 2004-11-16 Pfizer Prod Inc Directly compressible azithromycin formulations
FR2834890B1 (en) * 2002-01-23 2004-02-27 Servier Lab ORODISPERSIBLE PHARMACEUTICAL COMPOSITION OF AGOMELATIN
JP2005526095A (en) * 2002-03-20 2005-09-02 エラン ファーマ インターナショナル，リミティド Rapid dissolution dosage form with low friability

Similar Documents

Publication Publication Date Title
AU2003291103A1 (en) Pharmaceutical composition
GB0210397D0 (en) Pharmaceutical formulations
AU2002257582A1 (en) Pharmaceutical formulation
AU2003250372A1 (en) Pharmaceutical composition
AU2003901813A0 (en) Pharmaceutical derivatives
AU2002302147A1 (en) Pharmaceutical composition
AU2002364468A1 (en) Solid orally-dispersible pharmaceutical formulation
AU2003260803A1 (en) Sustained release pharmaceutical composition
AU2003245504A1 (en) Pharmaceutical compositions for drugs having ph-dependentsolubility
HUP0303948A2 (en) Solid orally-dispersible pharmaceutical formulation
AU2003226487A1 (en) Formulation
GB2392093B (en) Pharmaceutical formulations
AU2003217110A1 (en) Novel formulation
AU2003284460A1 (en) Medicinal composition
AU2003291642A1 (en) Pyrazoloazepine compounds as pharmaceutical agents
AU2003280387A1 (en) Pharmaceutical formulation comprising azithrocycin monohydrate
AU2003216503A1 (en) Stable pharmaceutical compositions
AU2003280799A1 (en) Medicinal composition
AU2003244942A1 (en) Controlled-release pharmaceutical formulations
AU2003280678A1 (en) Medicinal composition
AU2003238900A1 (en) Pharmaceutical formulation
AUPS188302A0 (en) Pharmaceutical composition
AUPR529701A0 (en) Pharmaceutical composition
AU2002950788A0 (en) Pharmaceutical formulation
AUPS087402A0 (en) Pharmaceutical formulations